Our Annual Report
Our year in review
Neuroblastoma Australia’s Annual Reports provide a summary of what we achieved, the impact we’ve made and how we worked towards our mission to find safer and more effective treatments for the devastating childhood cancer neuroblastoma.
Thanks to the dedication of our supporters we will have invested over $4 million in research by early 2025. We are a small charity but are focused on continuing our growth so we can achieve our goal – better, safer, kinder treatments for neuroblastoma. Investment in the charity and its resources is required to take us to the next stage and with more events and supporters we are confident we can keep moving forward.
Read the Latest Report
Previous Reports
- Neuroblastoma Australia Annual Report 2022 – 2023
- Neuroblastoma Australia Annual Report 2021 – 2022
- Neuroblastoma Australia Annual Report 2020 – 2021
- Neuroblastoma Australia Annual Report 2019 – 2020
- Neuroblastoma Australia Annual Report 2018 – 2019
Financials
Neuroblastoma Australia was a volunteer charity until 2016 donating 100% of proceeds to research. In 2016 the charity took on the challenge of growing and developing with the ambition of raising more funds. The charity employed people for the first time and has invested in improving overall resources and skills to be able to achieve its mission more effectively.
The charity’s main costs are the event costs which however provide the bulk of fundraising. Please refer to our audited Financial Reports below.
We are delighted to have the services of Pro You accountants to conduct the auditing our accounts.
Current Financials
Previous Financials
- 2023 to 2024 Financials
- 2022 to 2023 Financials
- 2021 to 2022 Financials
- 2020 to 2021 Financials
- 2019 to 2020 Financials
- 2018 to 2019 Financials
- 2017 to 2018 Financials
- 2016 to 2017 Financials